Lyme

by Mary Beth Pfeiffer

  Basile, R.C., N.H. Yoshinari, E. Mantovani, et al. “Brazilian Borreliosis with Special Emphasis on Humans and Horses.” Brazilian Journal of Microbiology 48, no. 1 (2017): 167–72.

  Berende, A., H., J.M. ter Hofstede, F.J. Vos, et al. “Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.” New England Journal of Medicine 374, no. 13 (2016): 1209–20.

  Berry, K., J. Bayham, S.R. Meyer, et al. “The Allocation of Time and Risk of Lyme: A Case of Ecosystem Service Income and Substitution Effects.” Environmental and Resource Economics April (2017): 1–20.

  Blanc, F., N. Philippi, B. Cretin, et al. “Lyme Neuroborreliosis and Dementia.” Journal of Alzheimer’s Disease 41, no. 4 (2014): 1087–93.

  Bockenstedt, L.K., D.G. Gonzalez, A.M. Haberman, et al. “Spirochete Antigens Persist near Cartilage after Murine Lyme Borreliosis Therapy.” Journal of Clinical Investigation 122, no. 7 (2012): 2652–60.

  Bockenstedt, L.K., J. Mao, E. Hodzic, et al. “Detection of Attenuated, Noninfectious Spirochetes in Borrelia Burgdorferi-Infected Mice after Antibiotic Treatment.” Journal of Infectious Diseases 186, no. 10 (2002): 1430–37.

  Bockenstedt, L.K., and J.D. Radolf. “Editorial Commentary: Xenodiagnosis for Posttreatment Lyme Disease Syndrome: Resolving the Conundrum or Adding to It?” Clinical Infectious Diseases 58, no. 7 (2014): 946–48.

  Borgermans, L., G. Goderis, J. Vandevoorde, et al. “Relevance of Chronic Lyme Disease to Family Medicine as a Complex Multidi- mensional Chronic Disease Construct: A Systematic Review.” Inter- national Journal of Family Medicine 2014 (2014): 138016.

  Bransfield, R. “Suicide and Lyme and Associated Diseases.” Neuropsychiatric Disease and Treatment 13 (2017): 1575–87.

  ———“Lyme Disease, Comorbid Tick-Borne Diseases, and Neuropsychiatric Disorders.” Psychiatric Times 24, no. 14 (2007): 59–62.

  Breitschwerdt, E.B. “Did Bartonella Henselae Contribute to the Deaths of Two Veterinarians?” Parasites & Vectors 8, no. 1 (2015): 317.

  Breitschwerdt, E.B., B.C. Hegarty, R.G. Maggi, et al. “Rickettsia Rickettsii Transmission by a Lone Star Tick, North Carolina.” Emerging Infectious Diseases 17, no. 5 (2011): 873–5.

  Breitschwerdt, E.B., R.G. Maggi, P. Farmer, et al. “Molecular Evidence of Perinatal Transmission of Bartonella Vinsonii Subsp. Berkhoffii and Bartonella Henselae to a Child.” Journal of Clinical Microbiology 48, no. 6 (2010): 2289–93.

  Breitschwerdt, E.B., R.G. Maggi, W.L. Nicholson, et al. “Bartonella sp. Bacteremia in Patients with Neurological and Neurocognitive Dysfunction.” Journal of Clinical Microbiology 9, no. 46 (2008): 2856–61.

  Burdge, D.R., and D.P. O’Hanlon. “Experience at a Referral Center for Patients with Suspected Lyme Disease in an Area of Nonendemicity: First 65 Patients.” Clinical Infectious Diseases 16, no. 4 (1993): 558–60.

  Burgdorfer, W. “Discovery of the Lyme Disease Spirochete and Its Relation to Tick Vectors.” Yale Journal of Biology and Medicine 57, no. 4 (1984): 515–20.

  Burgdorfer, W., R.S. Lane, A.G. Barbour, et al. “The Western Black-Legged Tick, Ixodes Pacificus: A Vector of Borrelia Burgdorferi.” American Journal of Tropical Medicine and Hygiene 34, no. 5 (1985): 925–30.

  Cairns, V., and J. Godwin. “Post-Lyme Borreliosis Syndrome: A Meta-Analysis of Reported Symptoms.” International Journal of Epidemiology 34, no. 6 (2005): 1340–45.

  Cameron, D.J., L.B. Johnson, and E.L. Maloney. “Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease.” Expert Review of Anti-Infective Therapy 12, no. 9 (2014): 1103–35.

  Capasso, L. “5300 years ago, the Ice Man Used Natural Laxatives and Antibiotics.” Lancet 352, no. 9143 (1998): 1864.

  Caskey, J.R., and M.E. Embers. “Persister Development by Borrelia burgdorferi Populations In Vitro.” Antimicrobial Agents and Chemotherapy. 59, no. 10 (2015): 6288-6295.

  Centers for Disease Control and Prevention. 2008. “Surveillance for Lyme Disease—United States, 1992–2006.” Morbidity and Mortality Weekly 2013. “CDC Provides Estimate of Americans Diagnosed with Lyme Disease Each Year.” 2013. “Three Sudden Cardiac Deaths Associated with Lyme Carditis—United States, November 2012–July 2013.” Morbidity and Mortality Weekly Report. 2015. “Lyme Disease: Signs and Symptoms of Untreated Lyme Disease.” 2016. “Final 2015 Reports of Nationally Notifiable Infectious Diseases and Conditions.” Morbidity and Mortality Weekly Report. 2016. “Post-Treatment Lyme Disease Syndrome.” 2016. “Natural Tick Repellents and Pesticides.” 2016. “Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States.” 2017. “Antibiotic/Antimicrobial Resistance.” 2017. “Research into Prolonged Treatment for Lyme Disease.”

  Cerar, T., F. Strle, D. Stupica, et al. “Differences in Genotype, Clinical Features, and Inflammatory Potential of Borrelia Burgdorferi Sensu Stricto Strains from Europe and the United States.” Emerging Infectious Diseases 22, no. 5 (2016): 818–27.

  Chalada, M.J., J. Stenos, and R.S. Bradbury. “Is There a Lyme-like Disease in Australia? Summary of the Findings to Date.” One Health 2 (2016): 42–54.

  Cheng, A., D. Chen, K. Woodstock, et al. “Analyzing the Potential Risk of Climate Change on Lyme Disease in Eastern Ontario, Canada, Using Time Series Remotely Sensed Temperature Data and Tick Population Modelling.” Remote Sensing 9, no. 6 (2017): 609.

  Chmela, J., J. Kotál, J. Kopecký, et al. “All for One and One for All on the Tick-Host Battlefield.” Trends in Parasitology 32, no. 5 (2016): 368–77.

  Chmielewska-Badora, J., E. Cisak, and J. Dutkiewicz. “Lyme Borreliosis and Multiple Sclerosis: Any Connection? A Seroepidemic Study.” Annals of Agricultural and Environmental Medicine 7, no. 2 (2000): 141–3.

  Clark, K.L., B. Leydet, and S. Hartman. “Lyme Borreliosis in Human Patients in Florida and Georgia, USA.” International Journal of Medical Sciences 10, no. 7 (2013): 915–31.

  Clarke, C.S., E.T. Rogers, and E.L. Egan. “Babesiosis: Under-Reporting or Case-Clustering?” Postgraduate Medical Journal 65, no. 766 (1989): 591–3.

  Cohen, E. B., L.D. Auckland, P. P. Marra, and S. A. Hamer. 2015. “Avian Migrants Facilitate Invasions of Neotropical Ticks and Tick-Borne Pathogens into the United States.” Applied and Environmental Microbiology, October, AEM.02656–15.

  Commins, S., S. Satinover, J. Hosen, et al. “Delayed Anaphylaxis, Angioedema, or Urticaria after Consumption of Red Meat in Patients with IgE Antibodies Specific for Galactose-Alpha-1,3-Galactose.” Journal of Allergy and Clinical Immunology 123, no. 2 (2009): 426–33.

  Cook, M., and B. Puri. “Application of Bayesian Decision-Making to Laboratory Testing for Lyme Disease and Comparison with Testing for HIV.” International Journal of General Medicine 10, April (2017): 113–23.

  Cook, M., and B. Puri. “Commercial Test Kits for Detection of Lyme Borreliosis: A Meta-Analysis of Test Accuracy.” International Journal of General Medicine 9 (2016): 427–40.

  Costello, J.M., M.E. Alexander, K.M. Greco, et al. “Lyme Carditis in Children: Presentation, Predictive Factors, and Clinical Course.” Pediatrics 123, no. 5 (2009): e835–41.

  County of Fairfax. 2016. A Study Report on the Use of 4-Poster Deer Treatment Stations to Control Tick Infestations on White-tailed Deer (Odocoileus virginianus) in Fairfax County, Virginia. Fairfax, Va.

  Crimmins, A., J. Balbus, J.L. Gamble, et al., eds. The Impacts of Climate Change on Human Health in the United States: A Scientific Assessment. Washington, DC: U.S. Global Change Research Program, 2016.

  Cutler, S.J., E. Ruzic-Sabljic, and A. Potkonjak. “Emerging Borreliae – Expanding beyond Lyme Borreliosis.” Molecular and Cellular Probes 31 (2017): 22–27.

  Dahlgren, F.S., C.D. Paddock, Y.P. Springer, et al. “Expanding Range of Amblyomma Americanum and Simultaneous Changes in the Epidemiology of Spotted Fever Group Rickettsiosis in the United States.” American Journal of Tropical Medicine and Hygiene 94, no. 1 (
2016): 35–42.

  Dattwyler, R., D.J. Volkman, B.J. Luft, et al. “Seronegative Lyme Disease. Dissociation of Specific T- and B-lymphocyte Responses to Borrelia Burgdorferi.” New England Journal of Medicine 319, no. 22 (1988): 1441–466.

  De Groot, M., B. Baker, and E. Bird. “Practical Test of Tick-resistant Work Wear.” (Translated from Dutch). Association of Forest Owners and Nature Terrain, 2013.

  DeBiasi, R.L. “A Concise Critical Analysis of Serologic Testing for the Diagnosis of Lyme Disease.” Current Infectious Disease Reports 16, no. 12 (2014): 450.

  Dell’Amore, C. “What’s a Ghost Moose? How Ticks Are Killing an Iconic Animal.” National Geographic June (2015): 1.

  DeLong, A.K., B. Blossom, E. Maloney, et al. “Antibiotic Retreatment of Lyme Disease in Patients with Persistent Symptoms: A Biostatistical Review of Randomized, Placebo-Controlled, Clinical Trials.” Contemporary Clinical Trials 33, no. 6 (2012): 1132–42.

  Department of Defense. “Lyme Disease among U.S. Military Members, Active and Reserve Component, 2001–2008.” Medical Surveillance Monthly Report 16, no. 7 (2009): 2–4.

  Dersch, R., T. Hottenrott, S. Schmidt, et al. “Efficacy and Safety of Pharmacological Treatments for Lyme Neuroborreliosis in Children: A Systematic Review.” BMC Neurology 16, no. 1 (2016): 189.

  Dersch, R., H. Sommer, S. Rauer, et al. “Prevalence and Spectrum of Residual Symptoms in Lyme Neuroborreliosis after Pharmacological Treatment: A Systematic Review.” Journal of Neurology 263, no. 1 (2015): 17–24.

  Diuk-Wasser, M.A., E. Vannier, and P.J. Krause. “Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences.” Trends in Parasitology 32, no. 1 (2016): 30–42.

  Donta, S.T. “Tetracycline Therapy for Chronic Lyme Disease.” Clinical Infectious Diseases 25, no. s1, Suppl. 1 (1997): S52–6.

  Donta, S.T., R.B. Noto, and J.A. Vento. “SPECT Brain Imaging in Chronic Lyme Disease.” Clinical Nuclear Medicine 37, no. 9 (2012): e219–22.

  Dressler, F., J.A. Whalen, B.N. Reinhardt, et al. “Western Blotting in the Serodiagnosis of Lyme Disease.” Journal of Infectious Diseases 167, no. 2 (1993): 392–400..

  Dunn, J.M., P.J. Krause, S. Davis, et al. “Borrelia Burgdorferi Promotes the Establishment of Babesia Microti in the Northeastern United States.” PLoS One 9, no. 12 (2014): e115494.

  Ebady, R., A.F. Niddam, A.E. Boczula, et al. “Biomechanics of Borrelia Burgdorferi Vascular Interactions.” Cell Reports 16, no. 10 (2016): 2593–604.

  Ehrlich, G.D., R. Veeh, X. Wang, et al. “Mucosal Biofilm Formation on Middle-Ear Mucosa in the Chinchilla Model of Otitis Media.” Journal of the American Medical Association 287, no. 13 (2002): 1710–15.

  Eisen, L., D. Rose, R. Prose, N. Breuner, M. Dolan, K. Thompson, and N. Connally. 2017. “Bioassays to Evaluate Non-Contact Spatial Repellency, Contact Irritancy, and Acute Toxicity of Permethrin-Treated Clothing against Nymphal Ixodes Scapularis Ticks.” Ticks and Tick-borne Diseases, October:837–49.

  Eisen, R.J., L. Eisen, and C.B. Beard. “County-Scale Distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the Continental United States.” Journal of Medical Entomology 53, no. 2 (2016): 349–86.

  Elbaum-Garfinkle, S. “Close to Home: A History of Yale and Lyme Disease.” Yale Journal of Biology and Medicine 84, no. 2 (2011): 103–8.

  Elliott, D.J., S.C. Eppes, and J.D. Klein. “Teratogen Update: Lyme Disease.” Teratology 64, no. 5 (2001): 276–81.

  Elsner, R.A., C.J. Hastey, K.J. Olsen, et al. “Suppression of Long-Lived Humoral Immunity Following Borrelia Burgdorferi Infection.” PLoS Pathogens 11, no. 7 (2015): e1004976.

  Embers, M.E., S.W. Barthold, J.T. Borda, et al. “Persistence of Borrelia Burgdorferi in Rhesus Macaques Following Antibiotic Treatment of Disseminated Infection.” PLoS One 7, no. 1 (2012): e29914.

  Embers, M.E., and S. Narasimhan. “Vaccination against Lyme Disease: Past, Present, and Future.” Frontiers in Cellular and Infection Microbiology 3, no. 6 (2013).

  Environmental Protection Agency, Climate Change Indicators in the United States, 2014, 3rd ed.” EPA 430-R-14–004.

  Fallon, B.A., J.G. Keilp, K.M. Corbera, et al. “A Randomized, Placebo- Controlled Trial of Repeated IV Antibiotic Therapy for Lyme Encephalopathy.” Neurology 70, no. 13 (2008): 992–1003.

  Fallon, B.A., J. Keilp, I. Prohovnik, et al. “Regional Cerebral Blood Flow and Cognitive Deficits in Chronic Lyme Disease.” Journal of Neuro- psychiatry and Clinical Neurosciences 15, no. 3 (2003): 326–32.

  Fallon, B.A., J.M. Kochevar, A. Gaito, et al. “The Underdiagnosis of Neuropsychiatric Lyme Disease in Children and Adults.” Psychiatric Clinics of North America 21, no. 3 (1998): 693–703.

  Fallon, B.A., and J.A. Nields. “Lyme Disease: A Neuropsychiatric Illness.” American Journal of Psychiatry 151, no. 11 (1994): 1571–83.

  Fallon, B.A., E. Petkova, J.G. Keilp, et al. “A Reappraisal of the U.S. Clinical Trials of Post-Treatment Lyme Disease Syndrome.” Open Neurology Journal 6, Suppl 1 (2012): 79–87.

  Fang, D.C., and J. McCullough. “Transfusion-Transmitted Babesia Microti.” Transfusion Medicine Reviews 30, no. 3 (2016): 132–38.

  Feder, H.M., Jr., B.J.B. Johnson, S. O’Connell, et al., and the Ad Hoc International Lyme Disease Group. “A Critical Appraisal of ‘Chronic Lyme Disease.’” New England Journal of Medicine 357, no. 14 (2007): 1422–30.

  Feng, J., P.G. Auwaerter, and Y. Zhang. “Drug Combinations against Borrelia Burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline.” PLoS One 10, no. 3 (2015): e0117207.

  Feng, J., W. Shi, S. Zhang, et al. “A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia Burgdorferi Persisters from an FDA Drug Library.” Frontiers in Microbiology 7 (2016): 743.

  Feng, J., T. Wang, W. Shi, et al. “Identification of Novel Activity against Borrelia Burgdorferi Persisters Using an FDA Approved Drug Library.” Emerging Microbes & Infections 3, no. 7 (2014): e49.

  Feng, J., S. Zhang, W. Shi, et al. “Activity of Sulfa Drugs and Their Combinations against Stationary Phase B. burgdorferi In Vitro.” Antibiotics (Basel, Switzerland) 6, no. 1 (2017): 10.

  Fife, C.E., and K.A. Eckert. “Hyperbaric Oxygen Therapy and Chronic Lyme Disease: The Controversy and the Evidence.” In Textbook of Hyperbaric Medicine, ed. Kewal K. Jain, 171–81. Switzerland: Springer, 2016.

  Fraser, C.M., S. Casjens, W.M. Huang, et al. “Genomic Sequence of a Lyme Disease Spirochaete, Borrelia Burgdorferi.” Nature 390, no. 6660 (1997): 580–86.

  Gaff, H.D., A. White, K. Leas, et al. “TickBot: A Novel Robotic Device for Controlling Tick Populations in the Natural Environment.” Ticks and Tick-Borne Diseases 6, no. 2 (2015): 146–51.

  Gardner, T. “Lyme Disease.” In Infectious Diseases of the Fetus and Newborn Infant, ed. J.S. Remington and J.O. Klein, 519–642. Philadelphia: Saunders, 2001.

  Ginsberg, H.S., M. Albert, L. Acevedo, et al. “Environmental Factors Affecting Survival of Immature Ixodes Scapularis and Implications for Geographical Distribution of Lyme Disease: The Climate/Behavior Hypothesis.” PLoS One 12, no. 1 (2017): e0168723.

  Godfrey, E.R., and S.E. Randolph. “Economic Downturn Results in Tick-borne Disease Upsurge.” Parasites & Vectors 4, no. 1 (2011): 35.

  Government of Canada. “National Lyme Disease Surveillance in Canada 2013: Web Report.”

  Grab, D.J., G. Perides, J.S. Dumler, et al. “Borrelia Burgdorferi, Host-Derived Proteases, and the Blood-Brain Barrier.” Infection and Immunity 73, no. 2 (2005): 1014–22.

  Grann, D. 2001. “Stalking Dr. Steere” The New York Times Magazine, June 17.

  Granter, S.R., R.S. Ostfeld, and D.A. Milner Jr. “Where the Wild Things Aren’t: Loss of Biodiversity, Emerging Infectious Diseases, and Implications for Diagnosticians.” American Journal of Clinical Pathology 146, no. 6 (2016): 644–6.

  Gray, J.S., H. Dautel, A. Estrada-Peña, et al. “Effects of Climat
e Change on Ticks and Tick-Borne Diseases in Europe.” Interdisciplinary Perspectives on Infectious Diseases 2009 (2009): 1–12.

  Habeggar, S. 2014. “Lyme Disease in Canada: An Update on the Epidemiology.” Purple Paper (43).

  Hájek, T., B. Pašková, D. Janovská, et al. “Higher Prevalence of Antibodies to Borrelia Burgdorferi in Psychiatric Patients than in Healthy Subjects.” American Journal of Psychiatry 159, no. 2 (2002): 297–301.

  Han, S., G.J. Hickling, and J.I. Tsao. “High Prevalence of Borrelia miyamotoi among Adult Blacklegged Ticks from White-Tailed Deer.” Emerging Infectious Diseases 22, no. 2 (2016): 316–18.

  Hao, Q., X. Hou, Z. Geng, et al. “Distribution of Borrelia Burgdorferi Sensu Lato in China.” Journal of Clinical Microbiology 49, no. 2 (2011): 647–50.

  Hasle, G. “Transport of Ixodid Ticks and Tick-Borne Pathogens by Migratory Birds.” Frontiers in Cellular and Infection Microbiology 3, September (2013): 1–6.

  Hermance, M.E., and S. Thangamani. “Powassan Virus: An Emerging Arbovirus of Public Health Concern in North America.” Vector-Borne and Zoonotic Diseases (Larchmont, N.Y.) 17, no. 7 (2017): 453–62.

  Herman-Giddens, M.E. “Tick-Borne Diseases in the South-East Need Human Studies: Lyme Disease, STARI and Beyond.” Zoonoses and Public Health 61, no. 1 (2014): 1–3.

  Herrmann, C., and L. Gern. “Search for Blood or Water Is Influenced by Borrelia Burgdorferi in Ixodes Ricincus Parasites & Vectors 8, no. 1 (2015): 6.

  Hersh, M.H., R.S. Ostfeld, D.J. McHenry, et al. “Co-Infection of Blacklegged Ticks with Babesia Microti and Borrelia Burgdorferi Is Higher than Expected and Acquired from Small Mammal Hosts.” PLoS One 9, no. 6 (2014): e99348.

  Herwaldt, B.L., J.V. Linden, E. Bosserman, et al. “Transfusion-Associated Babesiosis in the United States: A Description of Cases.” Annals of Internal Medicine 155, no. 8 (2011): 509–19.

  Hodzic, E., D. Imai, S. Feng, et al. “Resurgence of Persisting Non-Cultivable Borrelia Burgdorferi following Antibiotic Treatment in Mice.” PLoS One 9, no. 1 (2014): e86907.